1. Home
  2. AGCO vs MDGL Comparison

AGCO vs MDGL Comparison

Compare AGCO & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGCO
  • MDGL
  • Stock Information
  • Founded
  • AGCO 1990
  • MDGL 2011
  • Country
  • AGCO United States
  • MDGL United States
  • Employees
  • AGCO N/A
  • MDGL N/A
  • Industry
  • AGCO Industrial Machinery/Components
  • MDGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • AGCO Industrials
  • MDGL Health Care
  • Exchange
  • AGCO Nasdaq
  • MDGL Nasdaq
  • Market Cap
  • AGCO 8.1B
  • MDGL 9.6B
  • IPO Year
  • AGCO 1992
  • MDGL N/A
  • Fundamental
  • Price
  • AGCO $108.92
  • MDGL $420.19
  • Analyst Decision
  • AGCO Hold
  • MDGL Strong Buy
  • Analyst Count
  • AGCO 10
  • MDGL 12
  • Target Price
  • AGCO $116.80
  • MDGL $521.09
  • AVG Volume (30 Days)
  • AGCO 721.1K
  • MDGL 270.6K
  • Earning Date
  • AGCO 10-31-2025
  • MDGL 11-04-2025
  • Dividend Yield
  • AGCO 3.37%
  • MDGL N/A
  • EPS Growth
  • AGCO N/A
  • MDGL N/A
  • EPS
  • AGCO 1.34
  • MDGL N/A
  • Revenue
  • AGCO $10,172,100,000.00
  • MDGL $515,547,000.00
  • Revenue This Year
  • AGCO N/A
  • MDGL $394.38
  • Revenue Next Year
  • AGCO $4.61
  • MDGL $64.73
  • P/E Ratio
  • AGCO $81.40
  • MDGL N/A
  • Revenue Growth
  • AGCO N/A
  • MDGL 3421.98
  • 52 Week Low
  • AGCO $73.79
  • MDGL $201.22
  • 52 Week High
  • AGCO $121.16
  • MDGL $463.63
  • Technical
  • Relative Strength Index (RSI)
  • AGCO 51.25
  • MDGL 44.64
  • Support Level
  • AGCO $107.01
  • MDGL $413.82
  • Resistance Level
  • AGCO $109.32
  • MDGL $445.06
  • Average True Range (ATR)
  • AGCO 2.94
  • MDGL 16.35
  • MACD
  • AGCO 0.32
  • MDGL -3.80
  • Stochastic Oscillator
  • AGCO 69.57
  • MDGL 17.11

About AGCO AGCO Corporation

Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: